Small molecule NADPH(NOX2)-agonists
Development of small molecule agonist of FPR/NOX2(NADPH oxidase)
for treatment of inflammatory, autoimmune and infectious diseases
Contact
ProNoxis is exploring a wide range of business development opportunities spanning the discovery and development process.
For our preclinical R&D we are interested in entering co-development projects with academic and industrial partners for collaboration and joint development.
Please contact us if you are interested in collaborating with Pronoxis.
